120 related articles for article (PubMed ID: 15209436)
41. Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation.
Voorzanger-Rousselot N; Juillet F; Mareau E; Zimmermann J; Kalebic T; Garnero P
Br J Cancer; 2006 Aug; 95(4):506-14. PubMed ID: 16880790
[TBL] [Abstract][Full Text] [Related]
42. [N-terminal crosslinking telopeptide of type I collagen].
Fukunaga M
Nihon Rinsho; 2004 Dec; 62 Suppl 12():236-9. PubMed ID: 15658308
[No Abstract] [Full Text] [Related]
43. Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone.
Garnero P; Borel O; Gineyts E; Duboeuf F; Solberg H; Bouxsein ML; Christiansen C; Delmas PD
Bone; 2006 Mar; 38(3):300-9. PubMed ID: 16271523
[TBL] [Abstract][Full Text] [Related]
44. The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients.
Leeming DJ; Koizumi M; Byrjalsen I; Li B; Qvist P; Tankó LB
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):32-8. PubMed ID: 16434583
[TBL] [Abstract][Full Text] [Related]
45. The relationships between the degree of beta-isomerization of type I collagen degradation products in the urine and aging, menopause and osteoporosis with fractures.
Hoshino H; Takahashi M; Kushida K; Ohishi T; Inoue T
Osteoporos Int; 1999; 9(5):405-9. PubMed ID: 10550459
[TBL] [Abstract][Full Text] [Related]
46. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Bone resorption marker; urinary and serum CTX].
Gorai I
Clin Calcium; 2006 Jun; 16(6):1001-8. PubMed ID: 16751697
[TBL] [Abstract][Full Text] [Related]
47. MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone.
Incorvaia L; Badalamenti G; Rini G; Arcara C; Fricano S; Sferrazza C; Di Trapani D; Gebbia N; Leto G
Anticancer Res; 2007; 27(3B):1519-25. PubMed ID: 17595770
[TBL] [Abstract][Full Text] [Related]
48. Clinical usefulness of serum pyridinoline cross-linked carboxyterminal telopeptide of type I collagen for diagnosis of bone metastases in patients with primary lung cancer.
Yokoyama T; Yamamoto M; Shima K; Suzuki K; Sako C; Ito G; Kume M; Maeda M
Respirology; 2005 Jun; 10(3):300-4. PubMed ID: 15955141
[TBL] [Abstract][Full Text] [Related]
49. Increased Dickkopf-1 expression in breast cancer bone metastases.
Voorzanger-Rousselot N; Goehrig D; Journe F; Doriath V; Body JJ; Clézardin P; Garnero P
Br J Cancer; 2007 Oct; 97(7):964-70. PubMed ID: 17876334
[TBL] [Abstract][Full Text] [Related]
50. A cross-sectional study of bone turnover markers in healthy premenopausal women.
de Papp AE; Bone HG; Caulfield MP; Kagan R; Buinewicz A; Chen E; Rosenberg E; Reitz RE
Bone; 2007 May; 40(5):1222-30. PubMed ID: 17331821
[TBL] [Abstract][Full Text] [Related]
51. Surface plasmon resonance detection of interactions between peptide fragments of N-telopeptide and its monoclonal antibodies.
Lung FD; Chen CH; Liou CC; Chen HY
J Pept Res; 2004 Apr; 63(4):365-70. PubMed ID: 15102054
[TBL] [Abstract][Full Text] [Related]
52. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
Brown JE; Cook RJ; Major P; Lipton A; Saad F; Smith M; Lee KA; Zheng M; Hei YJ; Coleman RE
J Natl Cancer Inst; 2005 Jan; 97(1):59-69. PubMed ID: 15632381
[TBL] [Abstract][Full Text] [Related]
53. Biochemical markers of bone turnover in patients with localized and metastasized prostate cancer.
Hegele A; Wahl HG; Varga Z; Sevinc S; Koliva L; Schrader AJ; Hofmann R; Olbert P
BJU Int; 2007 Feb; 99(2):330-4. PubMed ID: 17092281
[TBL] [Abstract][Full Text] [Related]
54. Age- and BMD-related differences in biochemical markers of bone metabolism in rural and urban women from Lublin Region, Poland.
Filip RS; Zagórski J
Ann Agric Environ Med; 2004; 11(2):255-9. PubMed ID: 15627333
[TBL] [Abstract][Full Text] [Related]
55. Effect of bed rest during pregnancy on bone turnover markers in pregnant and postpartum women.
Kaji T; Yasui T; Suto M; Mitani R; Morine M; Uemura H; Maeda K; Irahara M
Bone; 2007 Apr; 40(4):1088-94. PubMed ID: 17229597
[TBL] [Abstract][Full Text] [Related]
56. Lack of an acute effect of ghrelin on markers of bone turnover in healthy controls and post-gastrectomy subjects.
Huda MS; Durham BH; Wong SP; Dovey TM; McCulloch P; Kerrigan D; Pinkney JH; Fraser WD; Wilding JP
Bone; 2007 Sep; 41(3):406-13. PubMed ID: 17613297
[TBL] [Abstract][Full Text] [Related]
57. Comparison of biochemical markers of bone resorption in patients with metabolic and malignant bone diseases.
Withold W; Friedrich W; Reinauer H
Ann Clin Biochem; 1996 Sep; 33 ( Pt 5)():421-7. PubMed ID: 8888974
[TBL] [Abstract][Full Text] [Related]
58. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
[TBL] [Abstract][Full Text] [Related]
59. Effect of three doses of conjugated estrogens/medroxyprogesterone acetate on biomarkers of bone turnover and cartilage degradation in postmenopausal women: The Pan-Asia Menopause (PAM) study.
Ausmanas MK; Holinka CF; Ling YS; Christiansen C
Climacteric; 2007 Aug; 10(4):306-13. PubMed ID: 17653957
[TBL] [Abstract][Full Text] [Related]
60. Feto-maternal bone remodeling in normal pregnancy and preeclampsia.
Shaarawy M; Zaki S; Ramzi AM; Salem ME; El-Minawi AM
J Soc Gynecol Investig; 2005 Jul; 12(5):343-8. PubMed ID: 15979546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
